What to Know About Acute Myelogenous Leukemia (AML)

Introduction

Acute myelogenous leukemia (AML) is a fast-growing cancer of the blood and bone marrow that affects myeloid cells, which normally develop into white blood cells, red blood cells, and platelets. AML disrupts normal blood cell production, leading to severe health complications if left untreated.

Causes and Risk Factors

The exact cause of AML is not always known, but several factors can increase the risk of developing the disease, including:

  • Genetic mutations that affect blood cell growth.
  • Exposure to radiation or harmful chemicals like benzene.
  • Previous chemotherapy or radiation therapy for other cancers.
  • Blood disorders such as myelodysplastic syndromes.
  • Smoking, which increases exposure to harmful toxins.
  • Family history of leukemia or related conditions.

Symptoms of AML

AML symptoms often appear suddenly and worsen quickly. Common signs include:

  • Persistent fatigue and weakness.
  • Frequent infections due to a weakened immune system.
  • Unexplained bruising or prolonged bleeding.
  • Pale skin caused by anemia.
  • Shortness of breath.
  • Bone or joint pain.
  • Swollen lymph nodes, liver, or spleen.

Diagnosis and Tests

To diagnose AML, doctors use a combination of:

  • Blood tests – Detecting abnormal white blood cell counts.
  • Bone marrow biopsy – Confirming the presence of leukemia cells.
  • Genetic testing – Identifying mutations that may guide treatment.

Treatment Options

AML requires urgent treatment, which may include:

  • Chemotherapy – The primary treatment to destroy leukemia cells.
  • Targeted therapy – Using drugs that attack specific cancer cell mutations.
  • Stem cell transplant – Replacing diseased bone marrow with healthy donor cells.
  • Clinical trials – Testing new and experimental treatments.

Prognosis and Outlook

AML prognosis depends on factors like age, overall health, and genetic mutations. While aggressive, advances in treatment have improved survival rates, especially for younger patients. Early diagnosis and prompt treatment are crucial for better outcomes.

Conclusion

Acute myelogenous leukemia is a rapidly progressing blood cancer that requires immediate medical attention. Understanding its risk factors, symptoms, and treatment options can help with early detection and improve chances of successful treatment.